www.fdanews.com/articles/150126-results-of-lymphoseek-phase-iii-clinical-trials-in-melanoma-published-in-em-annals-of-surgical-oncology

Results of Lymphoseek Phase III Clinical Trials in Melanoma Published in Annals of Surgical Oncology

October 10, 2012

Navidea Biopharmaceuticals announced the peer-reviewed publication of results from two Phase III clinical trials of Lymphoseek (technetium 99m tilmanocept) in patients with melanoma of the skin.
Daily Finance